Acidrox M Chewable Tablet

Acidrox M is a hydroxymagnesium aluminate complex that is converted rapidly in gastric acid to Mg(OH)2 and Al(OH)3, which are absorbed poorly and thus provide a sustained antacid effect


Acidrox M is used to relieve symptoms of dyspepsia, heartburn, acid indigestion, sour stomach, gastroesophageal reflux, hiatal hernia and flatulence. It is also prescribed in hyperacidity associated with peptic ulcers, gastritis and esophagitis. Acidrox M may be given to children if necessary.

Acidrox M is also used to associated treatment for these conditions: Acid indigestion, Aspiration, Bloating, Calcinosis, Dyspepsia, Gastroesophageal Reflux, Gastrointestinal Bleeding, Heartburn, Hyperacidity, Hyperparathyroidism, Kidney Stones, Peptic Ulcer, Stress Ulcers

Trade Name Acidrox M
Generic Magaldrate
Other Names Aluminium magnesium hydroxide sulfate hydrate, Aluminum magnesium hydroxide sulfate hydrate, Aluminum magnesium hydroxide sulphate hydrate, Hydrate magnesium aluminate activated sulfate, Magaldrate, Magaldrato, Magaldratum, Magnesium aluminate hydrate, Monalium hydrate
Weight 400mg
Type Chewable Tablet
Formula Al5H33Mg10O40S2
Weight Average: 1115.3
Monoisotopic: 1111.7570627
Therapeutic Class Antacids, Anti-dyspeptic/Carminatives
Manufacturer Syntho Laboratories Ltd
Available Country Bangladesh
Last Updated: June 23, 2021 at 11:22 am


Acidrox M dosage

Tablet: 1-3 tablets, after meals and at bed time or as directed by the physician.

Syrup: 2 to 3 teaspoonful, 3 or 4 times daily, half to one hour after or before meal and at bedtime

Side Effects

Constipation and diarrhea may occur.

Food Interaction

  • Avoid alcohol.

Pregnancy & Breastfeeding use

Pregnant women: Acidrox M may be used in pregnancy if indicated however one should avoid excessive dosage.

Lactating mother: Acidrox M may pass into breast milk but has not been reported to cause problem in nursing babies.


Acidrox M is contraindicated in patients with known hypersensitivity to magnesium and aluminium. It is also contraindicated in patients with impaired renal function